section name header

Indications

REMS

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Neuro: headache, dizziness.

Misc: HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS) , infection (including cytomegalovirus [CMV] and Epstein-Barr virus [EBV] reactivation), MALIGNANCY, infusion-related events.

Interactions

Drug-Drug:

Availability

Route/Dosage

Rheumatoid Arthritis

Juvenile Idiopathic Arthritis

Psoriatic Arthritis

Prophylaxis of Acute Graft Versus Host Disease

US Brand Names

Orencia

Action

Therapeutic Effects:

Classifications

Therapeutic Classification: antirheumatics (DMARDs)

Pharmacologic Classification: fusion proteins

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Unknown.

Metabolism/Excretion: Unknown.

Half-life: 13 days.

Time/Action Profile

(improvement in symptoms)

ROUTEONSETPEAKDURATION
IVwithin 15 days–3 mo6–12 mo3 yr (maintenance of response)

Patient/Family Teaching

Pronunciation

a-BAT-a-cept audio

Code

NDC Code*